Hydration Pharmaceuticals Co Ltd
ASX:HPC
Cash Flow Statement
Cash Flow Statement
Hydration Pharmaceuticals Co Ltd
| Dec-2021 | Jun-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Stock-Based Compensation |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Change in Working Capital |
(8)
|
(9)
|
1
|
(6)
|
(5)
|
(4)
|
(3)
|
|
| Cash from Operating Activities |
(8)
N/A
|
(9)
-13%
|
1
N/A
|
(6)
N/A
|
(5)
+14%
|
(4)
+21%
|
(3)
+12%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
9
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
9
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
12
|
0
|
0
|
3
|
0
|
0
|
1
|
|
| Net Issuance of Debt |
6
|
0
|
0
|
0
|
1
|
(4)
|
(5)
|
|
| Other |
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Financing Activities |
17
N/A
|
11
-36%
|
(0)
N/A
|
3
N/A
|
4
+40%
|
(4)
N/A
|
(5)
-14%
|
|
| Change in Cash | ||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
9
N/A
|
2
-79%
|
1
-27%
|
(3)
N/A
|
(1)
+69%
|
1
N/A
|
1
-9%
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(8)
N/A
|
(9)
-13%
|
1
N/A
|
(6)
N/A
|
(5)
+14%
|
(4)
+21%
|
(3)
+12%
|
|